FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2126513931> ?p ?o ?g. }

• W2126513931 abstract "HomeHypertensionVol. 50, No. 2Polycystic Ovary Syndrome: Implications of Corticotropin in the Regulation of Blood Pressure, Aldosterone, and Androgen Secretion Free AccessLetterPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessLetterPDF/EPUBPolycystic Ovary Syndrome: Implications of Corticotropin in the Regulation of Blood Pressure, Aldosterone, and Androgen Secretion Decio Armanini, Donatella Pellati and Cristina Fiore Decio ArmaniniDecio Armanini Departments of Medical and Surgical Sciences-Endocrinology, University of Padua, Padua, Italy Search for more papers by this author , Donatella PellatiDonatella Pellati Departments of Medical and Surgical Sciences-Endocrinology, University of Padua, Padua, Italy Search for more papers by this author and Cristina FioreCristina Fiore Departments of Medical and Surgical Sciences-Endocrinology, University of Padua, Padua, Italy Search for more papers by this author Originally published18 Jun 2007https://doi.org/10.1161/HYPERTENSIONAHA.107.093690Hypertension. 2007;50:e24Other version(s) of this articleYou are viewing the most recent version of this article. Previous versions: June 18, 2007: Previous Version 1 To the Editor:In a recent issue of Hypertension, Chen et al1 have described a correlation between androgen levels and blood pressure in young women with polycystic ovary syndrome (PCOS), and this correlation was independent from age, insulin resistance, obesity, and dyslipidemia. We would like to discuss other factors involved in the interpretation of these data.High adrenal androgen levels in women with PCOS can also be related to an increase of corticotropin (ACTH). The major question is why ACTH could be responsible for an increase of adrenal androgens in PCOS. Previous reports have documented that patients with PCOS have reduced activity of 11β-hydroxysteroid dehydrogenase type 1, the enzyme that activates cortisone to cortisol.2 11β-Hydroxysteroid dehydrogenase type 1 may enhance the metabolic clearance rate of cortisol, thereby reducing negative feedback and increasing ACTH-dependent adrenal androgen production. It is interesting, at this point, that an extremely high increase of cortisone metabolites and of androgen concentrations are reported in some patients with PCOS and cortisone reductase deficiency.3In a recent paper by Cascella et al,4 a positive correlation was found between aldosterone and mean blood pressure in patients with PCOS and, more interestingly, between aldosterone and C- reactive protein, metabolic patterns, and intima-media thickness. Both androgens1 and aldosterone4 correlate with blood pressure, and these findings are consistent with chronic ACTH drive in adrenals of patients with PCOS.In fact, whereas administration of high amounts of ACTH for several days or 11-hydroxylase deficiency is associated with suppression of aldosterone and increase of deoxycorticosterone, a chronic ACTH drive because of a partial defect of 11β-hydroxysteroid dehydrogenase type 1 could activate aldosterone synthase at the level of adrenal glomerulosa and androgen secretion by the adrenal reticularis. We, therefore, suggest that a relative chronic increase of ACTH related to a slight deficiency of 11β-hydroxysteroid dehydrogenase type 1 can explain the reported hormonal pattern of these subjects.The correlation among aldosterone, oxidative stress, metabolism abnormalities, and blood pressure is consistent with a primary involvement of aldosterone and not of androgens in the increase of blood pressure. These data also support the possibility of therapy with spironolactone in patients with PCOS. The drug blocks both the proinflammatory status because of aldosterone binding to mineralocorticoid receptors and the clinical picture of hyperandrogenism because of the binding of androgens to androgen receptors. We have recently stressed these concepts in a study of women with PCOS.5DisclosuresNone.1 Chen MJ, Yang WS, Chen CL, Ho HN, Yang YS. Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome. Hypertension. 2007; 49: 1442–1447.LinkGoogle Scholar2 Stewart PM, Shackleton CH. Beastall GH, Edwards CR. 5Alpha-reductase activity in polycystic ovarian syndrome. Lancet. 1990; 335: 431–433.CrossrefMedlineGoogle Scholar3 Draper N, Walker EA, Bujalska IJ, Tomlinson JW, Chalder SM, Arlt W, Lavery GG, Bedendo O, Ray DW, Laing I, Malunowicz E, White PC, Hewison M, Mason PJ, Connell JM, Shackleton CH, Stewart PM. Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Nat Genet. 2003; 34: 434–439.CrossrefMedlineGoogle Scholar4 Cascella T, Palomba S, Tauchmanova L, Manguso F, Di Biase S, Labella D, Giallauria F, Vigorito C, Colao A, Lombardi G, Orio F. Aldosterone concentration and cardiovascular risk in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2006; 91: 4395–4400.CrossrefMedlineGoogle Scholar5 Armanini D, Castello R, Scaroni C, Bonanni G, Faccini G, Pellati D, Bertoldo A, Fiore C, Moghetti P. Treatment of polycystic ovary syndrome with spironolactone plus licorice. Eur J Obstet Gynecol Reprod Biol. 2007; 131: 61–67.CrossrefMedlineGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Armanini D, Bordin L, Donà G, Sabbadin C, Bakdounes L, Ragazzi E, Giorgino F and Fiore C (2012) Polycystic ovary syndrome: Implications of measurement of plasma aldosterone, renin activity and progesterone, Steroids, 10.1016/j.steroids.2012.02.010, 77:6, (655-658), Online publication date: 1-May-2012. Chen M and Yang Y (2007) Response to Polycystic Ovary Syndrome: Implications of Corticotropin in the Regulation of Blood Pressure, Aldosterone, and Androgen Secretion, Hypertension, 50:2, (e25-e25), Online publication date: 1-Aug-2007. August 2007Vol 50, Issue 2 Advertisement Article InformationMetrics https://doi.org/10.1161/HYPERTENSIONAHA.107.093690PMID: 17576851 Originally publishedJune 18, 2007 PDF download Advertisement SubjectsEtiology" @default.
• W2126513931 created "2016-06-24" @default.
• W2126513931 creator A5000037947 @default.
• W2126513931 creator A5034700088 @default.
• W2126513931 creator A5055546265 @default.
• W2126513931 date "2007-08-01" @default.
• W2126513931 modified "2023-10-16" @default.
• W2126513931 title "Polycystic Ovary Syndrome: Implications of Corticotropin in the Regulation of Blood Pressure, Aldosterone, and Androgen Secretion" @default.
• W2126513931 cites W2090608637 @default.
• W2126513931 cites W2096677248 @default.
• W2126513931 cites W2104167472 @default.
• W2126513931 cites W2125564127 @default.
• W2126513931 cites W2140658230 @default.
• W2126513931 doi "https://doi.org/10.1161/hypertensionaha.107.093690" @default.
• W2126513931 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17576851" @default.
• W2126513931 hasPublicationYear "2007" @default.
• W2126513931 type Work @default.
• W2126513931 sameAs 2126513931 @default.
• W2126513931 citedByCount "2" @default.
• W2126513931 countsByYear W21265139312012 @default.
• W2126513931 crossrefType "journal-article" @default.
• W2126513931 hasAuthorship W2126513931A5000037947 @default.
• W2126513931 hasAuthorship W2126513931A5034700088 @default.
• W2126513931 hasAuthorship W2126513931A5055546265 @default.
• W2126513931 hasBestOaLocation W21265139311 @default.
• W2126513931 hasConcept C126322002 @default.
• W2126513931 hasConcept C134018914 @default.
• W2126513931 hasConcept C2777391703 @default.
• W2126513931 hasConcept C2777911890 @default.
• W2126513931 hasConcept C2778096610 @default.
• W2126513931 hasConcept C2778525890 @default.
• W2126513931 hasConcept C3018442814 @default.
• W2126513931 hasConcept C511355011 @default.
• W2126513931 hasConcept C71315377 @default.
• W2126513931 hasConcept C71924100 @default.
• W2126513931 hasConcept C84393581 @default.
• W2126513931 hasConceptScore W2126513931C126322002 @default.
• W2126513931 hasConceptScore W2126513931C134018914 @default.
• W2126513931 hasConceptScore W2126513931C2777391703 @default.
• W2126513931 hasConceptScore W2126513931C2777911890 @default.
• W2126513931 hasConceptScore W2126513931C2778096610 @default.
• W2126513931 hasConceptScore W2126513931C2778525890 @default.
• W2126513931 hasConceptScore W2126513931C3018442814 @default.
• W2126513931 hasConceptScore W2126513931C511355011 @default.
• W2126513931 hasConceptScore W2126513931C71315377 @default.
• W2126513931 hasConceptScore W2126513931C71924100 @default.
• W2126513931 hasConceptScore W2126513931C84393581 @default.
• W2126513931 hasIssue "2" @default.
• W2126513931 hasLocation W21265139311 @default.
• W2126513931 hasLocation W21265139312 @default.
• W2126513931 hasOpenAccess W2126513931 @default.
• W2126513931 hasPrimaryLocation W21265139311 @default.
• W2126513931 hasRelatedWork W1835582227 @default.
• W2126513931 hasRelatedWork W2022955668 @default.
• W2126513931 hasRelatedWork W2055600249 @default.
• W2126513931 hasRelatedWork W2102089120 @default.
• W2126513931 hasRelatedWork W2116183842 @default.
• W2126513931 hasRelatedWork W2162054361 @default.
• W2126513931 hasRelatedWork W2904480208 @default.
• W2126513931 hasRelatedWork W3028840175 @default.
• W2126513931 hasRelatedWork W4240163782 @default.
• W2126513931 hasRelatedWork W4246690683 @default.
• W2126513931 hasVolume "50" @default.
• W2126513931 isParatext "false" @default.
• W2126513931 isRetracted "false" @default.
• W2126513931 magId "2126513931" @default.
• W2126513931 workType "article" @default.